Medical Developments International Limited
Symbol: MVP.AX
ASX
0.59
AUDTrhová cena dnes
-1.9991
Pomer P/E
-0.0070
Pomer PEG
50.92M
MRK Cap
- 0.00%
Výnos DIV
Medical Developments International Limited (MVP-AX) Finančné výkazy
Súvaha
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 97.88 | 24.7 | 20.4 | 36.3 | |||||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.net-receivables | 26.01 | 8.9 | 6.2 | 5 | |||||||||||||||||||||
balance-sheet.row.inventory | 35.57 | 8.4 | 7.1 | 5.7 | |||||||||||||||||||||
balance-sheet.row.other-current-assets | 3.35 | 0.8 | 0.6 | 0.4 | |||||||||||||||||||||
balance-sheet.row.total-current-assets | 162.8 | 42.8 | 34.4 | 47.4 | |||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 46.89 | 12.1 | 11.6 | 11.7 | |||||||||||||||||||||
balance-sheet.row.goodwill | 7.62 | 3.8 | 3.8 | 4.4 | |||||||||||||||||||||
balance-sheet.row.intangible-assets | 92.91 | 8.5 | 8 | 8.2 | |||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 100.53 | 12.3 | 11.8 | 12.6 | |||||||||||||||||||||
balance-sheet.row.long-term-investments | 32.04 | -3.8 | -3.8 | -4.4 | |||||||||||||||||||||
balance-sheet.row.tax-assets | 45.75 | 16.3 | 14.8 | 2.2 | |||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 22.91 | 29.9 | 32.7 | 30.6 | |||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 248.12 | 66.7 | 67 | 52.8 | |||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.total-assets | 410.92 | 109.5 | 101.4 | 100.2 | |||||||||||||||||||||
balance-sheet.row.account-payables | 47.97 | 13.3 | 9.4 | 3.3 | |||||||||||||||||||||
balance-sheet.row.short-term-debt | 1.41 | 0.4 | 0.3 | 0.3 | |||||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 9.08 | 2.2 | 2.5 | 2.7 | |||||||||||||||||||||
Deferred Revenue Non Current | 27.5 | 1.9 | 21.6 | 21.9 | |||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 17.31 | - | - | - | |||||||||||||||||||||
balance-sheet.row.other-current-liab | 2.73 | 1.6 | 0.7 | 3.3 | |||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 55.4 | 12.6 | 33.6 | 24.9 | |||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 9.08 | 2.2 | 2.5 | 2.7 | |||||||||||||||||||||
balance-sheet.row.total-liab | 108.23 | 28.2 | 44.1 | 31.9 | |||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.common-stock | 393.8 | 105.7 | 77 | 76.9 | |||||||||||||||||||||
balance-sheet.row.retained-earnings | -109.4 | -30.2 | -24.5 | -12.1 | |||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 18.28 | 5.7 | 4.9 | 3.5 | |||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 302.68 | 81.3 | 57.3 | 68.3 | |||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 410.92 | 109.5 | 101.4 | 100.2 | |||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.total-equity | 302.68 | 81.3 | 57.3 | 68.3 | |||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 410.92 | - | - | - | |||||||||||||||||||||
Total Investments | 32.04 | -3.8 | -3.8 | -4.4 | |||||||||||||||||||||
balance-sheet.row.total-debt | 10.49 | 2.6 | 2.8 | 3 | |||||||||||||||||||||
balance-sheet.row.net-debt | -87.39 | -22.1 | -17.6 | -33.2 |
Výkaz peňažných tokov
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -21.58 | -5.6 | -12.4 | -12.6 | ||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 6.14 | 3.1 | 2.9 | 3.7 | ||||||||||||||||||||
cash-flows.row.deferred-income-tax | -16.12 | -7.4 | -8.4 | -0.1 | ||||||||||||||||||||
cash-flows.row.stock-based-compensation | 7.08 | 1.3 | 1 | 1.2 | ||||||||||||||||||||
cash-flows.row.change-in-working-capital | -9.12 | -2.5 | -3.6 | -9.9 | ||||||||||||||||||||
cash-flows.row.account-receivables | -1.4 | -2.9 | -2.5 | 1.4 | ||||||||||||||||||||
cash-flows.row.inventory | -3.45 | -1.8 | -1.4 | 0.2 | ||||||||||||||||||||
cash-flows.row.account-payables | 0.48 | 4.8 | 2.3 | 1 | ||||||||||||||||||||
cash-flows.row.other-working-capital | -2.87 | -2.6 | -2.1 | -12.5 | ||||||||||||||||||||
cash-flows.row.other-non-cash-items | 4.83 | -5.4 | 9.8 | 8.9 | ||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -28.71 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -11.45 | -7.7 | -5.2 | -6.6 | ||||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.other-investing-activites | -7.54 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -11.45 | -7.7 | -5.2 | -6.6 | ||||||||||||||||||||
cash-flows.row.debt-repayment | -0.26 | -0.3 | -0.2 | -0.1 | ||||||||||||||||||||
cash-flows.row.common-stock-issued | 28.57 | 28.3 | 0.4 | 36.3 | ||||||||||||||||||||
cash-flows.row.common-stock-repurchased | -0.53 | -1.7 | 0 | -0.7 | ||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -26.4 | -0.1 | -35.5 | ||||||||||||||||||||
cash-flows.row.other-financing-activites | 27.79 | 28.1 | 0.1 | 36.1 | ||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 27.54 | 28.1 | 0.1 | 36.1 | ||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0.05 | 0.4 | -0.1 | 0 | ||||||||||||||||||||
cash-flows.row.net-change-in-cash | -12.58 | 4.3 | -15.9 | 20.7 | ||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 97.88 | 24.7 | 20.4 | 36.3 | ||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 110.45 | 20.4 | 36.3 | 15.5 | ||||||||||||||||||||
cash-flows.row.operating-cash-flow | -28.71 | -16.5 | -10.7 | -8.8 | ||||||||||||||||||||
cash-flows.row.capital-expenditure | -11.45 | -7.7 | -5.2 | -6.6 | ||||||||||||||||||||
cash-flows.row.free-cash-flow | -40.16 | -24.2 | -15.9 | -15.4 |
Riadok výkazu ziskov a strát
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 60.19 | 32.3 | 21.9 | 25.3 | |||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 58.93 | 34.9 | 25 | 8.6 | |||||||||||||||||||||
income-statement-row.row.gross-profit | 1.26 | -2.5 | -3.1 | 16.7 | |||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||
income-statement-row.row.research-development | 0.34 | - | - | - | |||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 34.33 | - | - | - | |||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 6.63 | - | - | - | |||||||||||||||||||||
income-statement-row.row.other-expenses | 0 | 19.1 | 0 | 0 | |||||||||||||||||||||
income-statement-row.row.operating-expenses | 40.96 | 17.8 | 12.6 | 21.9 | |||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 99.89 | 52.6 | 37.6 | 30.5 | |||||||||||||||||||||
income-statement-row.row.interest-income | 0.93 | 0.7 | 0.5 | 0.1 | |||||||||||||||||||||
income-statement-row.row.interest-expense | 0.19 | 0.1 | 0.1 | 0.1 | |||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 6.63 | - | - | - | |||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 12.96 | 12.8 | -0.2 | -9.7 | |||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 19.1 | 0 | 0 | |||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 12.96 | 12.8 | -0.2 | -9.7 | |||||||||||||||||||||
income-statement-row.row.interest-expense | 0.19 | 0.1 | 0.1 | 0.1 | |||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 6.14 | 3.1 | 2.9 | 3.7 | |||||||||||||||||||||
income-statement-row.row.ebitda-caps | -33.56 | - | - | - | |||||||||||||||||||||
income-statement-row.row.operating-income | -39.7 | -20.3 | -15.7 | -5.2 | |||||||||||||||||||||
income-statement-row.row.income-before-tax | -26.73 | -7.5 | -15.9 | -15 | |||||||||||||||||||||
income-statement-row.row.income-tax-expense | -5.15 | -1.9 | -3.5 | -2.4 | |||||||||||||||||||||
income-statement-row.row.net-income | -21.58 | -5.6 | -12.4 | -12.6 |
Často kladené otázky
Čo je Medical Developments International Limited (MVP.AX) celkové aktíva?
Medical Developments International Limited (MVP.AX) celkové aktíva sú 109486000.000.
Aký je ročný obrat podniku?
Ročné príjmy sú 33494000.000.
Aké je ziskové rozpätie podniku?
Zisková marža firmy je -0.215.
Aký je voľný peňažný tok podniku?
Voľný peňažný tok je -0.239.
Aká je čistá zisková marža podniku?
Čistá zisková marža je -0.574.
Aké sú celkové výnosy podniku?
Celkové príjmy sú -0.750.
Aká je Medical Developments International Limited (MVP.AX) čistý zisk (čistý príjem)?
Čistý zisk (čistý príjem) je -5609000.000.
Aký je celkový dlh firmy?
Celkový dlh je 2560000.000.
Aké je číslo prevádzkových nákladov?
Prevádzkové výdavky sú 17757000.000.
Aký je údaj o hotovosti spoločnosti?
Peňažné prostriedky podniku sú 15699000.000.